I truly hope you are correct, but the variables in this trial are already highly complex and numerous, to add follow-on treatments and unexpected deaths to the mix does not help with the statistics.
Most here know that I am long (to the extreme), underwater (to the extreme), and invested in a number of ways, with January options and December warrants to the extreme.
However, I am a scientist and I try to be realistic, so I understand that this trial is confounded and I understand what that means scientifically.
As I have mentioned on a number of occasions and Flipper has highlighted today, there will need to be a confirmatory trial, even if it is a short one. I expect once the results are unblinded that DCVax-L will still be made available on a compassionate use basis while the confirmatory trial is conducted. This only makes sense.
News 
Market Data 
Discover 
AI
